$ZTS (-2.04%) You are close to the 52-week low, if the support holds it may go up again. Pros are the high market value, the company makes a profit and pays dividends. Cons are the fundamental data such as P/E ratio and P/B ratio. I will take a look at $ELAN (+2.43%) , $PETS (+3.99%)
$PETQ (-0.36%) in the watchlist
Elanco AnimalUS28414H1032ELANELAN
Financials
Market Cap
$7.24B5Y beta
1.41EPS (TTM)
-$2.547Free Float
491.07MRevenue (TTM)
$4.49BEBITDA (TTM)
$972.00MFree Cashflow (TTM)
$425.00MPricing
Analyst Ratings
The price target is $19.67 and the stock is covered by 14 analysts.
Buy
8
Hold
5
Sell
1
Information
Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.